Despite mass devastation and setbacks from Covid-19, 2020 presented a huge opportunity for healthcare innovation in terms of regulatory changes, new reimbursement, advances in medical research and new models of care; attracting over $14.8B in VC funding. So where should we be investing now? Here’s my take on seven top areas.
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.